Skip to content

TEVA

Teva Pharmaceutical Industries Limited

Revenue to net income

Key figures

MetricLast 12 months5-year CAGR
Revenue$17.2B+0.7%
Gross profit$9.2B+3.0%
Operating income$1.4B—
Net income$506M—
EPS$0.43—
Free cash flow$1.2B+12.5%